Metal-Based Nanomaterials: Work as Drugs and Carriers against Viral Infections
Nanomaterials, 2021 Virus infection is one of the threats to the health of organisms, and finding suitable antiviral agents is one of the main tasks of current researchers.
Junlei Yang +5 more
doaj +1 more source
Infectious Agents and Cancer, 2022 Background Antiviral therapy has been shown to benefit long-term survival after curative hepatectomy in patients with hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) with high levels of HBV-DNA, but the impact of antiviral therapy on ...
Ziqiang Li +4 more
doaj +1 more source
, 2016 Antiviral therapy is one of the most exciting aspects of virology, since it has successfully employed basic science to generate very effective treatments for serious viral infections. Table 1 lists selected examples of those human viral diseases for which there are established antiviral drugs.
Richman, Douglas D., Nathanson, Neal
openaire +2 more sources
Varicella-zoster virus infections – antiviral therapy and diagnosis
GMS Infectious Diseases, 2016 Varicella-zoster virus is an important human pathogen that causes varicella after primary infection and zoster after recurrence. Following primary infection, the virus remains latently for life in dorsal root and cranial nerve ganglia.
Sauerbrei, Andreas
doaj +1 more source
Tracking TCRß sequence clonotype expansions during antiviral therapy using high-throughput sequencing of the hypervariable region [PDF]
, 2016 To maintain a persistent infection viruses such as hepatitis C virus (HCV) employ a range of mechanisms that subvert protective T cell responses. The suppression of antigen-specific T cell responses by HCV hinders efforts to profile T cell responses ...
Arvind H Patel +10 more
core +3 more sources
Zincophorin – biosynthesis in Streptomyces griseus and antibiotic properties
GMS Infectious Diseases, 2016 Zincophorin is a polyketide antibiotic that possesses potent activity against Gram-positive bacteria, including human pathogens. While a number of total syntheses of this highly functionalized natural product were reported since its initial discovery ...
Walther, Elisabeth +9 more
doaj +1 more source
Egyptian Liver Journal, 2020 Background The impact of direct-acting antivirals (DAAs) remains a debate, whether they accelerate the recurrence rate of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) after curative therapy.
Nevine Ibrahim Musa +2 more
doaj +1 more source
Cochrane acute respiratory infections group's stakeholder engagement project identified systematic review priority areas [PDF]
, 2018 Objective: Cochrane acute respiratory infections (ARIs) group conducts systematic reviews of the evidence for treatment and prevention of ARIs. We report the results of a prioritization project, aiming to identify highest priority systematic review ...
Clark, Justin +5 more
core +1 more source
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group. [PDF]
PLoS ONE, 2018 This study aimed to elucidate whether interferon (IFN)-free direct-acting antiviral (DAA) therapy for hepatitis C after curative treatment of hepatocellular carcinoma (HCC) promotes HCC recurrence in a real-world large-scale cohort.This multicenter study
Toshie Mashiba +24 more
doaj +1 more source
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents [PDF]
, 2017 Hepatitis C virus (HCV) chronic infection can be associated with extrahepatic manifestations such as mixed cryoglobulinaemia and lymphoproliferative disorders that are endowed with increased rates of morbidity and all-cause mortality.
Burra, Patrizia +13 more
core +1 more source